Computer-guided discovery of epigenetics drugs: molecular modeling and identification of inhibitors of DNMT1 by Yoo, Jakyung & Medina-Franco, José L
POSTER PRESENTATION Open Access
Computer-guided discovery of epigenetics drugs:
molecular modeling and identification of
inhibitors of DNMT1
Jakyung Yoo
*, José L Medina-Franco
From 7th German Conference on Chemoinformatics: 25 CIC-Workshop
Goslar, Germany. 6-8 November 2011
DNA methylation is a covalent chemical modification of
DNA catalyzed by DNA methyltransferases (DNMTs)
and plays a crucial role in epigenetic modifications. Inhi-
bition of DNMT is a promising strategy for the treat-
ment of various developmental and proliferative
diseases, particularly cancers. Molecular docking and
other computational approaches are increasingly being
used to explore the ligand-binding interactions of
DNMT inhibitors [1,2]. In this work we conducted
molecular docking of experimentally known active com-
pounds in the catalytic site of the recently published
crystal structure of DNMT1 [3]. Prior docking, the con-
formation of the catalytic site was modelled with mole-
cular dynamics into an active conformation. To our
knowledge, this is the first molecular modelling study
conducted with the catalytic binding site of this crystal
structure. Based on the docking results, we developed a
structure-based pharmacophore model. Molecular mod-
elling results were compared with the insights previously
obtained with a homology model of the methyltransfer-
ase domain of DNMT1 [4]. We also discuss the experi-
mental inhibitory activity and docking of a novel
DNMT1 inhibitor recently identified in our group [5].
Results of this work have direct implications in the
future computer-based screening and optimization of
inhibitors of DNMT1 and show that computational
approaches form part of multidisciplinary efforts to
further advance epigenetic therapies [1].
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